Current terminology for polycystic ovary syndrome (PCOS) is contributing to significant delays in patient diagnosis, according to research published in the Journal of Clinical Endocrinology & Metabolism. The data reveals that diagnostic delays average 2.3 years—a substantial gap that can impact treatment initiation and patient outcomes.
With 170 million women worldwide affected by PCOS, this diagnostic delay represents a critical public health concern. The condition’s misleading name, which emphasizes ovarian cysts, obscures its true nature as a complex metabolic and hormonal disorder. Many women with PCOS do not actually present with ovarian cysts, yet the terminology creates false impressions among both patients and healthcare providers.
Recognizing this problem, the Endocrine Society has established working groups to examine potential name changes that could improve diagnostic accuracy and patient understanding. Terminology reform may prove essential to reducing diagnostic delays and ensuring women receive timely, appropriate care.
Read the full article on GMJ Newsroom.
Was this article helpful?
